Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,233 | -15,509 | -12,155 | -4,076 | -6,391 |
| Depreciation Amortization | 35 | 27 | 23 | 11 | 43 |
| Accounts payable and accrued liabilities | -20 | 963 | -515 | 1,102 | 158 |
| Other Working Capital | 663 | 769 | 190 | -285 | 627 |
| Other Operating Activity | 1,541 | 808 | 2,581 | -1,892 | 579 |
| Operating Cash Flow | $-18,015 | $-12,942 | $-9,876 | $-5,140 | $-4,985 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19 | -8,980 | -9,979 | -7,504 | 0 |
| PPE Investments | -24 | -57 | -9 | -52 | -4 |
| Other Investing Activity | -2 | 296 | 2,491 | -6,503 | 0 |
| Investing Cash Flow | $-7 | $-8,741 | $-7,497 | $-14,060 | $-4 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 5,000 | N/A |
| Common Stock Issued | 37,160 | 28,564 | 18,179 | 9,581 | 5,543 |
| Financing Cash Flow | $37,160 | $28,564 | $18,179 | $14,581 | $5,543 |
| Beginning Cash Position | 9,097 | 2,216 | 1,410 | 6,029 | 5,475 |
| End Cash Position | 28,235 | 9,097 | 2,216 | 1,410 | 6,029 |
| Net Cash Flow | $19,138 | $6,881 | $806 | $-4,619 | $554 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,015 | -12,942 | -9,876 | -5,140 | -4,985 |
| Capital Expenditure | -24 | -57 | -9 | -52 | -4 |
| Free Cash Flow | -18,039 | -12,999 | -9,885 | -5,193 | -4,989 |